Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Nanumi Han"'
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTInterleukin-34 (IL-34) has been known as a factor that is involved with tumor progression and therapeutic resistance. However, there are limitations to addressing the mechanism of how IL-34 induces therapeutic resistance. Here, we show a mech
Externí odkaz:
https://doaj.org/article/444988661bf44caf8e8c6521c59364dd
Autor:
Nanumi Han, Delnur Anwar, Naoki Hama, Takuto Kobayashi, Hidefumi Suzuki, Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, Ken-ichiro Seino
Publikováno v:
Inflammation and Regeneration, Vol 40, Iss 1, Pp 1-10 (2020)
Abstract Background Interleukin (IL)-34 acts as an alternative ligand for the colony-stimulating factor-1 receptor and controls the biology of myeloid cells, including survival, proliferation, and differentiation. IL-34 has been reported to be expres
Externí odkaz:
https://doaj.org/article/636e3f9f24664908a7f1f2b5218ecf1e
Autor:
Naoki Hama, Takuto Kobayashi, Nanumi Han, Fumihito Kitagawa, Nabeel Kajihara, Ryo Otsuka, Haruka Wada, Hee-kyung Lee, Hwanseok Rhee, Yoshinori Hasegawa, Hideo Yagita, Muhammad Baghdadi, Ken-ichiro Seino
Publikováno v:
iScience, Vol 25, Iss 1, Pp 103713- (2022)
Externí odkaz:
https://doaj.org/article/3c647d2d12494482a43f376250cefb59
Autor:
Nanumi Han, Hye Yoon Jang, Naoki Hama, Takuto Kobayashi, Ryo Otsuka, Haruka Wada, Ken-ichiro Seino
Publikováno v:
STAR Protocols, Vol 2, Iss 2, Pp 100460- (2021)
Summary: Previously, we identified a therapy-resistant role of IL-34 in an immune checkpoint blockade in murine models. To investigate whether a similar mechanism is applicable in human tumors as well, we used this protocol for the selection of IL-34
Externí odkaz:
https://doaj.org/article/a2cb2e4ed81a4be184c077d74c0b7c85
Autor:
Takuto Kobayashi, Muhammad Baghdadi, Nanumi Han, Tomoki Murata, Naoki Hama, Ryo Otsuka, Haruka Wada, Manabu Shiozawa, Tomoyuki Yokose, Yohei Miyagi, Atsushi Takano, Yataro Daigo, Ken-Ichiro Seino
Publikováno v:
Immunological Medicine, Vol 42, Iss 4, Pp 169-175 (2019)
The mortality of colorectal cancer is expected to increase in some countries including the United States, which necessitates the identification of new molecules that help in prognosis assessment and survival improvement. In this brief report, we eval
Externí odkaz:
https://doaj.org/article/a8c55352f7f142968110df145e195cf2
Autor:
Naoki Hama, Takuto Kobayashi, Nanumi Han, Fumihito Kitagawa, Nabeel Kajihara, Ryo Otsuka, Haruka Wada, Hee-kyung Lee, Hwanseok Rhee, Yoshinori Hasegawa, Hideo Yagita, Muhammad Baghdadi, Ken-ichiro Seino
Publikováno v:
iScience, Vol 23, Iss 10, Pp 101584- (2020)
Summary: Interleukin-34 (IL-34) is an alternative ligand to colony-stimulating factor-1 (CSF-1) for the CSF-1 receptor that acts as a key regulator of monocyte/macrophage lineage. In this study, we show that tumor-derived IL-34 mediates resistance to
Externí odkaz:
https://doaj.org/article/ee7052bc3c064a0ba126c392526c794b
Autor:
Nanumi Han, Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Takuto Kobayashi, Haruka Wada, Keisuke Imafuku, Hiroo Hata, Ken-ichiro Seino
Publikováno v:
Inflammation and Regeneration, Vol 38, Iss 1, Pp 1-5 (2018)
Abstract Background Immunotherapies that target immune-checkpoint molecules such PD-1 have helped to achieve durable responses in melanoma treatment. However, 25% of melanoma patients who showed objective responses to PD-1 blockade develop resistance
Externí odkaz:
https://doaj.org/article/736d7f79a7ae48d2bdd1a3b38348a93c
Autor:
Ken-ichiro Seino, Yataro Daigo, Atsushi Takano, Tomoyuki Yokose, Yohei Miyagi, Kichizo Kaga, Yasuhiro Hida, Noriaki Sakuragi, Hidemichi Watari, Daisuke Endo, Wira Eka Putra, Nanumi Han, Hirotake Abe, Sayaka Nakanishi, Haruka Wada, Muhammad Baghdadi
Supplementary materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42806f327c0ad1b53e7db7a1849aa0be
https://doi.org/10.1158/0008-5472.22413122
https://doi.org/10.1158/0008-5472.22413122
Autor:
Ken-ichiro Seino, Yataro Daigo, Atsushi Takano, Tomoyuki Yokose, Yohei Miyagi, Kichizo Kaga, Yasuhiro Hida, Noriaki Sakuragi, Hidemichi Watari, Daisuke Endo, Wira Eka Putra, Nanumi Han, Hirotake Abe, Sayaka Nakanishi, Haruka Wada, Muhammad Baghdadi
IL-34 expression in cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4966fbe205693d0ff7e28dc644241a52
https://doi.org/10.1158/0008-5472.22413125
https://doi.org/10.1158/0008-5472.22413125
Autor:
Ken-ichiro Seino, Yataro Daigo, Atsushi Takano, Tomoyuki Yokose, Yohei Miyagi, Kichizo Kaga, Yasuhiro Hida, Noriaki Sakuragi, Hidemichi Watari, Daisuke Endo, Wira Eka Putra, Nanumi Han, Hirotake Abe, Sayaka Nakanishi, Haruka Wada, Muhammad Baghdadi
Correlation between IL-34 and clinic-pathological characteristics, and Cox's proportional hazards model analysis of prognostic factors for OS in NSCLC patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fc33ad4335c2fba6c615917cf92a61
https://doi.org/10.1158/0008-5472.22413119
https://doi.org/10.1158/0008-5472.22413119